Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a phase 2 cabozantinib study in recurrent or metastatic Merkel cell carcinoma is now displayed, including study design, participant criteria, and results. It indicates the trial was terminated for lack of accrual and is no longer recruiting.
    Difference
    47%
    Check dated 2026-11-09T12:57:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T12:29:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The clinical trial details are not available on the page.
    Difference
    1%
    Check dated 2026-10-26T15:56:58.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T20:49:40.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T03:50:31.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual content with an access-denied message. This prevents viewing the trial details and related information.
    Difference
    18%
    Check dated 2026-09-21T22:54:13.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.